AHA Scientific Sessions 2025 Abstract

EVOLocumab Very Early after Myocardial Infarction (EVOLVE-MI): A Pragmatic Randomized Multicenter International Trial - Design and Baseline Characteristics

Trial in peopleInterventions

The paper